Literature DB >> 15210908

Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes.

J M Partridge1, S J M Weatherby, J A Woolmore, D J Highland, A A Fryer, C L A Mann, M D Boggild, W E R Ollier, R C Strange, C P Hawkins.   

Abstract

Multiple sclerosis (MS) risk is determined by environment and genes. The authors investigated in 419 cases and 422 controls if polymorphism in the vitamin D receptor (VDR), melanocortin-1 receptor (MC1R), and tyrosinase (TYR) genes is linked with MS risk and outcome. VDR ff was associated with reduced (odds ratio [OR] = 0.59) and MC1R His294-encoding alleles with increased (OR = 2.21) risk. MC1R Glu84/Glu84 was linked with disability (OR = 5.65). These preliminary data suggest a role for these genes in MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210908     DOI: 10.1212/wnl.62.12.2323

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in South Eastern of Iran.

Authors:  Mehrnaz Narooie-Nejad; Maryam Moossavi; Adam Torkamanzehi; Ali Moghtaderi; Saeedeh Salimi
Journal:  J Mol Neurosci       Date:  2015-02-18       Impact factor: 3.444

2.  Vitamin D receptor gene as a candidate gene for Parkinson disease.

Authors:  Megan W Butler; Amber Burt; Todd L Edwards; Stephan Zuchner; William K Scott; Eden R Martin; Jeffery M Vance; Liyong Wang
Journal:  Ann Hum Genet       Date:  2011-03       Impact factor: 1.670

3.  Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.

Authors:  K Claire Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Mult Scler       Date:  2009-12-09       Impact factor: 6.312

Review 4.  Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies.

Authors:  Kalthoum Tizaoui; Wajih Kaabachi; Agnès Hamzaoui; Kamel Hamzaoui
Journal:  Cell Mol Immunol       Date:  2014-07-07       Impact factor: 11.530

Review 5.  Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studies.

Authors:  Yan-Jie Zhang; Li Zhang; Shan-Yu Chen; Guo-Jun Yang; Xiao-Lei Huang; Yu Duan; Li-Juan Yang; Dong-Qing Ye; Jing Wang
Journal:  Neurol Sci       Date:  2017-11-06       Impact factor: 3.307

6.  The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.

Authors:  Andrew W Taylor; Nobuyoshi Kitaichi
Journal:  Brain Behav Immun       Date:  2008-01-02       Impact factor: 7.217

7.  The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study.

Authors:  Pavel Křenek; Yvonne Benešová; Julie Bienertová-Vašků; Anna Vašků
Journal:  J Mol Neurosci       Date:  2018-03-28       Impact factor: 3.444

8.  Genetic determinants of hair color and Parkinson's disease risk.

Authors:  Xiang Gao; Kelly C Simon; Jiali Han; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

9.  Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.

Authors:  Sarah-Michelle Orton; Andrew P Morris; Blanca M Herrera; Sreeram V Ramagopalan; Matthew R Lincoln; Michael J Chao; Reinhold Vieth; A Dessa Sadovnick; George C Ebers
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

10.  Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis.

Authors:  Elena García-Martín; José A G Agúndez; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.